National Veterinary Care Ltd share price up 2% on settled acquisitions

Credit: AllieKF

The National Veterinary Care Ltd (ASX: NVL) share price has risen by 2% so far today due to news of its settled acquisitions.

The company announced that it has settled the remaining two veterinary clinics of the four that it announced in December last year. The new clinics are established businesses in south east Queensland.

The acquisitions were primarily funded by debt. National Vet Care has acquired 11 clinics so far in FY18, with full-year revenue of $14.7 million and earnings before interest and tax (EBIT) of $3.1 million. The business now has a total of 64 veterinary clinics.

So what?

I think National Vet Care is the small cap most likely to deliver market-beating returns, even if it doesn’t deliver the biggest return out of all the possible options.

The rollup strategy is a simple, but effective one. The business just needs to keep acquiring clinics at good prices, whilst keeping the balance sheet in good shape and implementing its best-of-practice processes.

The veterinary clinic industry is a great one to be invested in. The number of pets is growing, the willingness of pet owners to spend on their pets is growing and pet insurance utilisation is growing.

National Vet Care has consistent, defensive earnings because around two thirds of cats and three quarters of dogs go to the vet each year. Price increases should be a good boost to organic growth as well.

Foolish takeaway

Management predicted that statutory revenue will grow by at least 25% in FY18, which could be a major boost to earnings per share if margins stay the same or grow. I’d be happy to buy shares at today’s price for a long-term hold.

I’d also be happy to consider these top shares at the current prices.

Top 3 ASX Blue Chips To Buy In 2018

For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked..

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool’s Top 3 Blue Chip Stocks for 2018."

Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.

The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies moves – we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor Tristan Harrison owns shares of NATVETCARE FPO. The Motley Fool Australia owns shares of NATVETCARE FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.